Abstract
In recent years environmental research has centered on emerging contaminants, outstanding among which are pharmaceutical products. Although pharmaceuticals have been detected in aquatic ecosystems only at trace levels, they have been shown to induce toxic effects in aquatic organisms since they are designed to be biologically active in living organisms and persistent to biodegradation and to have long half-lives. Effluents from domestic, hospital and industrial sources, sewage treatment plant effluent, and the inappropriate disposal of unused or expired medicines are the principal sources of emission of pharmaceuticals into the environment. Conventional methods of wastewater treatment prove insufficient for the complete removal of pharmaceuticals; however, research is now being focused on advanced oxidation processes to remove pharmaceutical products. Information on the fate and effects of pharmaceuticals in the environment provides the groundwork from which to assess their environmental risk and identify possible risk management strategies, as well as for putting in place stricter regulations on the fate of this type of contaminants.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bowe L (2016) Investigating emergent contaminants: pharmaceutical impacts and possible solutions. http://penbay.net/pollution/pharmaceut_pollutants_2016_leah_bowe.pdf. Accessed 20 Sept 2017
World Health Organization (2016) WHO Collaborating Centre for Drug Statistics and Methodology. https://www.whocc.no/atc_ddd_index/. Accessed 20 Sept 2017
Daughton CG (2003) Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy. Environ Health Perspect 111(5):757–774
Environmental Protection Agency (2008) United States Environmental Protection Agency. https://cfpub.epa.gov/si/si_public_record_report.cfm?dirEntryId=201706. Accessed 21 Sept 2017
Lapworth DJ, Baran N, Stuart ME et al (2012) Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ Pollut 163:287–303
Verlicchi P, Al Aukidy M, Galletti A et al (2012) Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci Total Environ 430:109–118
Vera-Candioti L, García MG, Galera MM et al (2008) Chemometric assisted solid-phase microextraction for the determination of anti-inflammatory and antiepileptic drugs in river water by liquid chromatography-diode array detection. J Chromatogr A 1211(1):22–32
Gros M, Petrović M, Barceló D (2006) Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 70(4):678–690
Jahnke A, Gandrass J, Ruck W (2004) Simultaneous determination of alkylphenol ethoxylates and their biotransformation products by liquid chromatography/electrospray ionisation tandem mass spectrometry. J Chromatogr A 1035(1):115–122
Benijts T, Dams R, Lambert W et al (2004) Countering matrix effects in environmental liquid chromatography-electrospray ionization tandem mass spectrometry water analysis for endocrine disrupting chemicals. J Chromatogr A 1029(1):153–159
Zrostlıkova J, Hajšlová J, Poustka J et al (2002) Alternative calibration approaches to compensate the effect of co-extracted matrix components in liquid chromatography-electrospray ionisation tandem mass spectrometry analysis of pesticide residues in plant materials. J Chromatogr A 973(1):13–26
Daughton CG (2008) Pharmaceuticals as environmental pollutants: the ramifications for human exposure. International encyclopedia of public health, vol 5. Academic Press, Oxford, pp 66–102
K’oreje KO, Vergeynst L, Ombaka D et al (2016) Occurrence patterns of pharmaceutical residues in wastewater, surface water and groundwater of Nairobi and Kisumu city, Kenya. Chemosphere 149:238–244
Fatta-Kassinos D, Meric S, Nikolaou A (2011) Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal Bioanal Chem 399(1):251–275
Kern S, Baumgartner R, Helbling DE et al (2010) A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment. J Environ Monit 12(11):2100–2111
Rodriguez-Mozaz S, de Alda MJL, Barceló D (2007) Advantages and limitations of on-line solid phase extraction coupled to liquid chromatography-mass spectrometry technologies versus biosensors for monitoring of emerging contaminants in water. J Chromatogr A 1152(1):97–115
Daughton CG (2001) Emerging pollutants, and communicating the science of environmental chemistry and mass spectrometry: pharmaceuticals in the environment. J Am Soc Mass Spectrom 12(10):1067–1076
The World Bank Group (2013) Sanitation, hygiene and wastewater resource guide: introduction to the wastewater treatment process. http://water.worldbank.org/shw-resource-guide/infrastructure/menu-technical-options/wastewater-treatment. Accessed 25 Sept 2017
Pescod MB (1992) Wastewater treatment and use in agriculture. FAO irrigation and drain paper 47
Stasinakis AS (2008) Use of selected advanced oxidation processes (AOPs) for wastewater treatment – a mini review. Global NEST J 10(3):376–385
Pieczyńska A, Fiszka Borzyszkowska A, Ofiarska A et al (2017) Removal of cytostatic drugs by AOPs: a review of applied processes in the context of green technology. Crit Rev Environ Sci Technol 17:58
Kommineni S, Zoeckler J, Stocking A et al (2000) Advanced oxidation processes. Treatment technologies for removal of methyl tertiary butyl ether (MTBE) from drinking water: air stripping, advanced oxidation processes, granular activated carbon and synthetic resin adsorbents2nd edn. National Water Research Institute, Fountain Valley, pp 109–208
Sharma S, Ruparelia JP, Patel ML (2011) A general review on advanced oxidation processes for wastewater treatment. In: International conference on current trends in technology. Institute of Technology, Nirma University, Ahmadabad, pp 382–481
Mota ALN, Albuquerque LF, Beltrame LC et al (2008) Advanced oxidation processes and their application in the petroleum industry: a review. Braz J Pet Gas 2(3):122–142
Conti ME, Cecchetti G (2001) Biological monitoring: lichens as bioindicators of air pollution assessment – a review. Environ Pollut 114(3):471–492
Van der Oost R, Beyer J, Vermeulen NP (2003) Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environ Toxicol Pharmacol 13(2):57–149
Zhou Q, Zhang J, Fu J et al (2008) Biomonitoring: an appealing tool for assessment of metal pollution in the aquatic ecosystem. Anal Chim Acta 606(2):135–150
Boening DW (1999) An evaluation of bivalves as biomonitors of heavy metals pollution in marine waters. Environ Monit Assess 55(3):459–470
Ondarza PM, Miglioranza KSB, Gonzalez M et al (2010) Organochlorine compounds in common carp (Cyprinus carpio) from Patagonia Argentina. J Braz Soc Ecotoxicol 5(1):41–47
De la Lanza G, Hernández S, Carbajal JL (2000) Organismos indicadores de la calidad del agua y contaminación (bioindicadores). Plaza y Valdés, Mexico City, pp 17–39
Sarkar A, Ray D, Shrivastava AN et al (2006) Molecular biomarkers: their significance and application in marine pollution monitoring. Ecotoxicology 15(4):333–340
Bucheli TD, Fent K (1995) Induction of cytochrome P450 as a biomarker for environmental contamination in aquatic ecosystems. Crit Rev Environ Sci Technol 25(3):201–268
Valavanidis A, Vlahogianni T, Dassenakis M et al (2006) Molecular biomarkers of oxidative stress in aquatic organisms in relation to toxic environmental pollutants. Ecotoxicol Environ Saf 64(2):178–189
Winston GW, Di Giulio RT (1991) Prooxidant and antioxidant mechanisms in aquatic organisms. Aquat Toxicol 19(2):137–161
Melancon MJ, Alscher R, Benson W et al (1992) Metabolic products as biomarkers. In: Huggett RJ (ed) Biomarkers: biochemical, physiological and histological markers of anthropogenic stress. Lewis, Boca Raton, pp 87–124
Sanders BM (1993) Stress proteins in aquatic organisms: an environmental perspective. Crit Rev Toxicol 23(1):49–75
Li ZH, Zlabek V, Velisek J et al (2011) Acute toxicity of carbamazepine to juvenile rainbow trout (Oncorhynchus mykiss): effects on antioxidant responses, hematological parameters and hepatic EROD. Ecotoxicol Environ Saf 74(3):319–327
Moss DW, Henderson AR, Kochmar JF (1986) Enzymes: principles of diagnostic enzymology and the aminotransferases. In: Tietz NW (ed) Textbook of clinical chemistry. WB Saunders, Philadelphia, pp 663–678
Pruett SB, Fan R, Zheng Q et al (2003) Modeling and predicting immunological effects of chemical stressors: characterization of a quantitative biomarker for immunological changes caused by atrazine and ethanol. Toxicol Sci 75(2):343–354
Wester PW, Vethaak AD, Van Muiswinkel WB (1994) Fish as biomarkers in immunotoxicology. Toxicology 86(3):213–232
Scholz S, Mayer I (2008) Molecular biomarkers of endocrine disruption in small model fish. Mol Cell Endocrinol 293(1):57–70
Spies RB, Stegeman JJ, Rice DW et al (1990) Sublethal responses of Platichthys stellatus to organic contamination in San Francisco Bay with emphasis on reproduction. In: McCarthy JF, Shugart LR (eds) Biomarkers of environmental contamination. Lewis, Chelsea, pp 87–122
Payne JF, Mathieu A, Melvin W et al (1996) Acetylcholinesterase, an old biomarker with a new future? Field trials in association with two urban rivers and a paper mill in Newfoundland. Mar Pollut Bull 32(2):225–231
Roos V, Gunnarsson L, Fick J et al (2012) Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection. Sci Total Environ 421:102–110
Küster A, Adler N (2014) Pharmaceuticals in the environment: scientific evidence of risks and its regulation. Philos Trans R Soc B 369(1656):20130587
European Environment Agency (2010) Pharmaceuticals in the environment – results of an EEA workshop. EEA technical report no 1/2010. Office for Official Publications of the European Communities, Luxembourg
EMEA (2006) European medicines agency. Pre-authorisation evaluation of medicines for human use. Committee for Medicinal Products for Human Use (CHMP) (Doc. Ref. EMEA/CHMP/SWP/ 4447/00)
Dix DJ, Houck KA, Martin MT et al (2006) The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95(1):5–12
Snyder S, Vanderford B, Pearson R et al (2003) Analytical methods used to measure endocrine disrupting compounds in water. Pract Period Hazard Toxic Radioact Waste Manage 7(4):224–234
McVey EA (2012) Regulation of pharmaceuticals in the environment: the USA. In: Brooks BW, Huggett DB (eds) Human pharmaceuticals in the environment. Springer, New York, pp 49–61
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
SanJuan-Reyes, N., Gómez-Oliván, L.M., Islas-Flores, H., Castro-Pastrana, L.I. (2017). Control of Environmental Pollution Caused by Pharmaceuticals. In: Gómez-Oliván, L. (eds) Ecopharmacovigilance. The Handbook of Environmental Chemistry, vol 66. Springer, Cham. https://doi.org/10.1007/698_2017_152
Download citation
DOI: https://doi.org/10.1007/698_2017_152
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73475-0
Online ISBN: 978-3-319-73476-7
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)